A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome
- 1 November 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 89 (5) , 561-568
- https://doi.org/10.1016/0002-9343(90)90173-b
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Psychiatric Status of Patients with the Chronic Fatigue SyndromeThe British Journal of Psychiatry, 1990
- WHAT IS MYALGIC ENCEPHALOMYELITIS?The Lancet, 1988
- IgG SUBCLASS DEFICIENCY AND CHRONIC FATIGUE SYNDROMEThe Lancet, 1988
- The Chronic Mononucleosis SyndromeThe Journal of Infectious Diseases, 1988
- CHRONIC ENTEROVIRUS INFECTION IN PATIENTS WITH POSTVIRAL FATIGUE SYNDROMEThe Lancet, 1988
- PATHOPHYSIOLOGY OF MYALGIC ENCEPHALITISThe Lancet, 1987
- Assessment of delayed-type hypersensitivity in man: A comparison of the “Multitest” and conventional intradermal injection of six antigensClinical Immunology and Immunopathology, 1985
- MONITORING THE SUBJECTIVE WELL‐BEING OF CHRONICALLY ILL PATIENTS OVER TIMECommunity Health Studies, 1984
- How Normal is Depression?Psychosomatics, 1972
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960